 |
|
New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics
January 05, 2009An international team led by University of Pittsburgh School of Medicine researchers has identified genetic markers associated with risk for ulcerative colitis. The findings, which appear today as an advance online publication of the journal Nature Genetics, bring researchers closer to understanding the biological pathways involved in the disease and may lead to the development of new treatments that specifically target them.
Ulcerative colitis is a chronic, relapsing disorder that causes inflammation and ulceration in the inner lining of the rectum and large intestine. The most common symptoms are diarrhea (oftentimes bloody) and abdominal pain. Ulcerative colitis and Crohn's disease, another chronic gastrointestinal inflammatory disorder, are the two major forms of inflammatory bowel disease (IBD).
"Ulcerative colitis and Crohn's disease are chronic conditions that impact the day-to-day lives of patients," said senior author of the study Richard H. Duerr, M.D., associate professor of medicine and human genetics at the University of Pittsburgh School of Medicine and Graduate School of Public Health. "IBD is most often diagnosed in the teenage years or early adulthood. While patients usually don't die from IBD, affected individuals live with its debilitating symptoms during the most productive years of their lives."
Because IBD tends to run in families, researchers have long thought that genetic factors play a role. Technology developed in recent years has enabled systematic, genome-wide searches for gene markers associated with common human diseases, and the discovery of more than 30 genetic risk factors for Crohn's disease has been one of the major success stories in this new era of research. While some genetic factors associated with Crohn's disease also predispose individuals to ulcerative colitis, markers specific for ulcerative colitis had yet to be found. To do so, researchers performed a genome-wide association study of hundreds of thousands of genetic markers using DNA samples from 1,052 individuals with ulcerative colitis and pre-exisiting data from 2,571 controls, all of European ancestry and residing in North America. Several genetic markers on chromosomes 1p36 and 12q15 showed highly significant associations with ulcerative colitis, and the association evidence was replicated in independent European ancestry samples from North America and southern Italy. Nearby genes implicated as possibly playing a role in ulcerative colitis include the ring finger protein 186 (RNF186), OTU domain containing 3 (OTUD3), and phospholipase A2, group IIE (PLA2G2E) - genes on chromosome 1p36, and the interferon, gamma (IFNG), interleukin 26 (IL26), and interleukin 22 (IL22) genes on chromosome 12q15. RNF186 and OTUD3 are members of gene families involved in protein turnover and diverse cellular processes. PLA2G2E, IFNG, IL26 and IL22 are known to play a role in inflammation and the immune response. The study also found highly suggestive associations between ulcerative colitis and genetic markers on chromosome 7q31 within or near the laminin, beta 1 (LAMB1) gene, which is a member of a gene family known to play a role in intestinal health and disease, and confirmed previously identified associations between ulcerative colitis and genetic variants in the interleukin 23 receptor (IL23R) gene on chromosome 1p31 and the major histocompatibility complex on chromosome 6p21.
"My laboratory is focused on studying the genetic basis for IBD," said Dr. Duerr. "Through genetic mapping, we and our collaborators are successfully identifying regions of the genome that contain IBD genes. The next steps are to understand the functional significance of IBD-associated genetic variants, and then to develop new treatments that specifically target biological pathways implicated by the genetic discoveries. The overall goal of this work is to improve the lives of the millions of patients worldwide that suffer from IBD."
University of Pittsburgh Schools of the Health Sciences
Because IBD tends to run in families, researchers have long thought that genetic factors play a role. Technology developed in recent years has enabled systematic, genome-wide searches for gene markers associated with common human diseases, and the discovery of more than 30 genetic risk factors for Crohn's disease has been one of the major success stories in this new era of research. While some genetic factors associated with Crohn's disease also predispose individuals to ulcerative colitis, markers specific for ulcerative colitis had yet to be found. To do so, researchers performed a genome-wide association study of hundreds of thousands of genetic markers using DNA samples from 1,052 individuals with ulcerative colitis and pre-exisiting data from 2,571 controls, all of European ancestry and residing in North America. Several genetic markers on chromosomes 1p36 and 12q15 showed highly significant associations with ulcerative colitis, and the association evidence was replicated in independent European ancestry samples from North America and southern Italy. Nearby genes implicated as possibly playing a role in ulcerative colitis include the ring finger protein 186 (RNF186), OTU domain containing 3 (OTUD3), and phospholipase A2, group IIE (PLA2G2E) - genes on chromosome 1p36, and the interferon, gamma (IFNG), interleukin 26 (IL26), and interleukin 22 (IL22) genes on chromosome 12q15. RNF186 and OTUD3 are members of gene families involved in protein turnover and diverse cellular processes. PLA2G2E, IFNG, IL26 and IL22 are known to play a role in inflammation and the immune response. The study also found highly suggestive associations between ulcerative colitis and genetic markers on chromosome 7q31 within or near the laminin, beta 1 (LAMB1) gene, which is a member of a gene family known to play a role in intestinal health and disease, and confirmed previously identified associations between ulcerative colitis and genetic variants in the interleukin 23 receptor (IL23R) gene on chromosome 1p31 and the major histocompatibility complex on chromosome 6p21.
"My laboratory is focused on studying the genetic basis for IBD," said Dr. Duerr. "Through genetic mapping, we and our collaborators are successfully identifying regions of the genome that contain IBD genes. The next steps are to understand the functional significance of IBD-associated genetic variants, and then to develop new treatments that specifically target biological pathways implicated by the genetic discoveries. The overall goal of this work is to improve the lives of the millions of patients worldwide that suffer from IBD."
University of Pittsburgh Schools of the Health Sciences
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Sleeping Sickness Pathogens Endangered Species Spinal Cord Coronary Heart Disease Wireless Childhood Obesity Kidney Disease Brain Disease Embryonic Development Loneliness Antibiotic Down syndrome Acupuncture Pneumococcal Disease Soil Erosion Nitrogen Smoking Sexual Behavior Bipolar Multiple Sclerosis Comet Dust Oxygen Dinosaurs Chromatin
See More: Science News Tags
Ulcerative Colitis Current Events and Ulcerative Colitis News RSSSubclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal
Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status.
Electronic Pill Shows Its Smarts by Measuring pH Levels in Digestive Tract
An electronic diagnostic tool called the SmartPill is swallowed by patients in order to take measurements as it travels through the gastrointestinal tract.
Enzyme involved in inflammatory bowel disease discovered at Penn State College of Medicine
Researchers at Penn State College of Medicine, working with biochemists, geneticists and clinicians at the University of Bern, Switzerland and in the United Kingdom, have discovered an enzyme that has a key role in inflammatory bowel disease (IBD).
UCLA cancer researchers first to link intestinal inflammation with systemic chromosome damage
UCLA scientists have linked for the first time intestinal inflammation with systemic chromosome damage in mice, a finding that may lead to the early identification and treatment of human inflammatory disorders.
Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?
Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease.
Helping Hand of Hybrid Surgery Benefits Colorectal Patients
Despite rapid strides in minimally invasive surgical techniques -- most notably, laparoscopy -- traditional open surgery remains the most common surgical option across the United States for people with diseases of the rectum and colon.
Scientists at Scripps Research identify a mutation that causes inflammatory bowel disease
A team of scientists at The Scripps Research Institute has linked a mouse mutation to an increased susceptibility for developing inflammatory bowel disease -- represented in humans as Crohn's disease and ulcerative colitis, which together are estimated to affect more than a million people in the United States.
Children with inflammatory bowel disease have surprisingly high folate levels, study finds
Children with newly diagnosed cases of inflammatory bowel disease have higher concentrations of folate in their blood than individuals without IBD, according to a new study led by researchers at the University of California, San Francisco and UC Berkeley.
UC HEALTH LINE: Spirituality May Help Adolescents Cope With Chronic Illness
Chronic illness can lead to poorer quality of life-particularly for adolescents. New research shows that spirituality may help teens cope with their conditions.
Identification of genetic markers for ulcerative colitis could lead to treatment
An international consortium of researchers, including major contribution from a team led by Dr. John D. Rioux, a professor of medicine at the Université de Montréal and the Montreal Heart Institute, has identified genetic markers associated with risk for ulcerative colitis.
More Ulcerative Colitis Current Events and Ulcerative Colitis News Articles
 |
Coping Successfully With Ulcerative Colitis (Overcoming Common Problems) by Peter Cartwright (Author) Ulcerative colitis is a disease that causes inflammation and sores in the top layers of the lining of the large intestine. The inflammation usually occurs in the rectum and lower part of the colon, but it may affect the entire colon. The inflammation makes the colon empty frequently, causing diarrhea. Ulcerative colitis occurs most often in people ages 15 to 40, although children and older people sometimes develop the disease. Ulcerative colitis affects men and women equally and appears to run in some families. There are 90,000 sufferers in the UK and 400,000 in the United States. This book covers: Causes Diagnosis Treatments Surgery Living with an ileostomy or a pouch Living with ulcerative colitis, including emotional issues and effects on the family Diet Ulcerative Colitis... |
 |
The First Year: Crohn's Disease and Ulcerative Colitis: An Essential Guide for the Newly Diagnosed (First Year, The) by Jill Sklar (Author), M.D. Manuel Sklar (Foreword) This newly revised edition includes new research and insights to help everyone newly diagnosed with IBD come to terms with their condition and the accompanying lifestyle changes – along with other vital information about IBD. |
 |
SedaCrohn - Crohn's Disease and Ulcerative Colitis by NoorHerbals SedaCrohn is a powerful herbal supplement containg the herb Artemisia Absinthium. It is specifically designed for sufferers from Crohn's Disease and Ulcerative Colitis. This highly effective product should provide relief after 1-3 weeks of usage. In contrast to the vast majority of other herbal products, SedaCrohn has been scientifically tested in clinical studies. Customers who are not satisfied, can request to receive their money back within 60 days for up to two bottles. No questions asked. An email to Amazon's supplier Noorherbals suffices. |
 |
What to Eat with IBD: A Comprehensive Nutrition and Recipe Guide for Crohn's Disease and Ulcerative Colitis by Tracie M Dalessandro MS RD CDN (Author) From a patient who is also a dietitian... Everything you need to know about nutrition and inflammatory bowel disease including healing foods, recipes, supplements and more. At the age of nineteen, author Tracie Dalessandro was diagnosed with ulcerative colitis and eventually Crohn's disease. After years of trying to heal, Dalessandro realized the power of using diet in conjunction with traditional medicine to control her inflammatory bowel disease (IBD), rather than allowing it to control her. Nutrition became the link between feeling sick and feeling well. What to Eat with IBD: A Comprehensive Nutrition and Recipe Guide for Crohn's Disease and Ulcerative Colitis is an invaluable resource containing the latest nutrition and diet information for those suffering from IBD.... |
 |
Ulcerative Colitis: Cause by GeneEd E-Learning The two most common forms of inflammatory bowel disease (IBD) are ulcerative colitis and Crohn's disease. Unlike Crohn's disease, which can occur anywhere in the digestive tract, ulcerative colitis usually affects only the innermost lining of the colorectal tract. This course examines the methods employed in diagnosing ulcerative colitis. eTextBooks from GeneEd are self-paced, multimedia courses designed for nurses (RNs), doctors (MDs and PhDs), clinical research associates (CRAs and monitors), clinical research coordinators (CRCs), investigators, researchers, other healthcare professionals, and patients. |
 |
The First Year: Crohn's Disease and Ulcerative Colitis: An Essential Guide for the Newly Diagnosed by Da Capo Press When Jill Sklar was diagnosed with Crohn’s disease in 1989, she quickly discovered the knowledge she sought—accessibly written medical information and guidance on practical, everyday coping skills—wasn’t available. Since then Sklar has educated herself on every aspect of the management and treatment of Crohn’s disease and ulcerative colitis—by reading medical and scientific books and journals, talking with doctors, and networking with other people who have Crohn’s or ulcerative colitis. She now shares her experience and knowledge with everyone who has been newly diagnosed. As a "patient-expert," Sklar walks you step-by-step through everything you need to do and learn each day of your first week after diagnosis, each subsequent week of the first month, and the following... |
 |
100 Questions & Answers About Crohn's Disease and Ulcerative Colitis: A Lahey Clinic Guide by Andrew S. Warner (Author), Amy E. Barto (Author) Approximately one million Americans may have Crohn's Disease and Ulcerative Colitis. Whether you're a newly diagnosed patient or a loved one of someone with Chrohn's Disease and Ulcerative Colitis, this book offers help. The only text to provide both the doctor's and patient's views, 100 Questions & Answers About Crohn's Disease and Ulcerative Colitis provides authoritative, practical answers to the most common questions asked by patients and their loved ones, including questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by Drs. Warner and Barto, with actual patient commentary, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of Crohn's Disease and Ulcerative Colitis. |
 |
VSL #3 Capsules (60 caps) by Sigma Tau Each sachet of VSL#3® contains 450 billion live lactic acid bacteria. This means that VSL#3® is the probiotic food supplement with the highest available concentration of live beneficial bacteria. |
 |
Native Remedies Digestion Tonic and DigestAssist ComboPack for fast relief from symptoms of IBS, Crohn's, indigestion, acid reflux, ulcerative colitis by Native Remedies The ComboPack of Digestion Tonic and DigestAssist consists of multiple remedies that work well together to provide increased support for your condition. This ComboPack assists with the long-term prevention and fast relief from symptoms of IBS, Crohn's, indigestion, acid reflux, ulcerative colitis and other digestive disorders. The Digestion Tonic promotes healthy digestion in anyone with digestive disorders or complaints while the DigestAssist can be taken as needed to quickly put an end to symptoms of heartburn, nausea, gas, indigestion, and acid reflux. |
 |
Colitis & Me: A Story of Recovery by Raman Prasad (Author) Narrative of an individual's successful recovery from inflammatory bowel disease. |
| © 2009 BrightSurf.com |